Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.

about

Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.

Item

http://www.wikidata.org/entity/Q47301897

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Positive prognostic value of H ...... OR in gastric cancer patients.

@en

Positive prognostic value of H ...... OR in gastric cancer patients.

@nl

type

Item

label

Positive prognostic value of H ...... OR in gastric cancer patients.

@en

Positive prognostic value of H ...... OR in gastric cancer patients.

@nl

prefLabel

Positive prognostic value of H ...... OR in gastric cancer patients.

@en

Positive prognostic value of H ...... OR in gastric cancer patients.

@nl

P1476

Positive prognostic value of H ...... OR in gastric cancer patients.

@en

P2093

Bo Chen

http://www.w3.org/2001/XMLSchema#string

Guo-Dong Cao

http://www.w3.org/2001/XMLSchema#string

Ke Chen

http://www.w3.org/2001/XMLSchema#string

Mao-Ming Xiong

http://www.w3.org/2001/XMLSchema#string

P2860

Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase

Oncogenic ERBB3 mutations in human cancers

Ebp1 isoforms distinctively regulate cell survival and differentiation

Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4

Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera

Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

P2888

s12885-017-3851-y

P304

841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1186/S12885-017-3851-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099597957

http://www.w3.org/2001/XMLSchema#string

P698

29233126

http://www.w3.org/2001/XMLSchema#string

P932

5727869

http://www.w3.org/2001/XMLSchema#string